Department of Gynecology, Faculty of Medicine, Akdeniz University, Antalya, Turkey
Department of Gynecology, University of Cologne, Koln, Germany.
Int J Gynecol Cancer. 2021 Mar;31(3):484-489. doi: 10.1136/ijgc-2020-001757.
Radical trachelectomy is a valid alternative to radical hysterectomy in women with a desire to retain their fertility. Data regarding the oncological outcomes of radical trachelectomy are comparable with those of radical hysterectomy but information regarding urinary and sexual function is limited. The aim of this study was to prospectively evaluate and compare quality of life, urinary and bowel symptoms, and sexual dysfunction between patients who underwent laparoscopic assisted vaginal radical trachelectomy versus radical hysterectomy for early-stage cervical cancer.
Patients who underwent laparoscopic assisted vaginal radical trachelectomy or radical hysterectomy along with sentinel or systemic pelvic lymphadenectomy were included between May 2015 and January 2017. Patients were asked to complete a validated questionnaire (German pelvic symptom questionnaire) on bladder, bowel, prolapse, and sexual function, and total pelvic score, at least 48 hours before surgery and 6 months after surgery.
A total of 51 patients were included. Of these, 26 patients (50.9%) underwent laparoscopic assisted vaginal radical trachelectomy and 25 (49.1%) underwent radical hysterectomy. No patient was converted to laparotomy. The majority of patients (76%) were diagnosed with International Federation of Gynecology and Obstetrics (FIGO 2018) stage 1B1 disease, with squamous cell carcinoma (54%) and grade II tumors (52%). Four patients (7.8 %) experienced perioperative complications (two grade II and two grade III complications according to the Clavien-Dindo classification). In the preoperative evaluation, the median scores for the four items of the questionnaire (bladder, bowel, prolapse, and sexual items) and total pelvic score were comparable between the two groups. The mean scores for radical hysterectomy and radical trachelectomy at the beginning of the study for bladder, bowel, prolapse, and sexual function were 0.93 versus 0.71, 0.71 versus 1.01, 0.12 versus 0.1, and 1.06 versus 1.0, respectively. On preoperative testing, the median scores for all four items of the questionnaire (p=0.821, p=0.126, p=0.449, p=0.965) and the total pelvic score (p=0.756) were comparable between the two groups. The radical hysterectomy group had worse total pelvic scores at the 6 month postoperative survey compared with baseline (p=0.03). There was no difference in bladder (p=0.07) or bowel symptoms (p=0.07) in the radical hysterectomy group comparing baseline with the 6 month assessment. Women undergoing radical hysterectomy experienced more urinary morbidity than women undergoing vaginal trachelectomy at 6 weeks (p=0.025). However, the mean bladder and pelvic scores in the 6 month control were comparable between patients who had and those who had not experienced urinary morbidity (p=0.127, p=0.480).
Patients undergoing laparoscopic assisted vaginal radical trachelectomy had similar pelvic scores in both the preoperative and postoperative periods. However, patients undergoing radical hysterectomy showed worse total pelvic scores on the postoperative assessment compared with the baseline evaluation. Urinary dysfunction in the early postoperative phase was more common in the radical hysterectomy group than in trachelectomy group.
在希望保留生育能力的女性中,根治性子宫颈切除术是根治性子宫切除术的有效替代方法。根治性子宫颈切除术的肿瘤学结果与根治性子宫切除术相当,但关于尿和性功能的信息有限。本研究旨在前瞻性评估和比较早期宫颈癌行腹腔镜辅助阴道根治性子宫颈切除术与根治性子宫切除术患者的生活质量、尿便症状和性功能。
2015 年 5 月至 2017 年 1 月期间,纳入行腹腔镜辅助阴道根治性子宫颈切除术或根治性子宫切除术联合前哨或全身盆腔淋巴结切除术的患者。患者在术前至少 48 小时和术后 6 个月,使用经过验证的问卷(德国盆腔症状问卷)完成膀胱、肠道、脱垂和性功能以及总盆腔评分的评估。
共纳入 51 例患者,其中 26 例(50.9%)行腹腔镜辅助阴道根治性子宫颈切除术,25 例(49.1%)行根治性子宫切除术。无一例患者转为剖腹手术。大多数患者(76%)诊断为国际妇产科联合会(FIGO 2018)2018 年第 1B1 期疾病,其中鳞状细胞癌(54%)和 II 级肿瘤(52%)。4 例(7.8%)发生围手术期并发症(根据 Clavien-Dindo 分级,2 例为 II 级,2 例为 III 级)。在术前评估中,两组问卷四项(膀胱、肠道、脱垂和性功能)和总盆腔评分的中位数相当。研究开始时,根治性子宫切除术和根治性子宫颈切除术的平均分数为膀胱、肠道、脱垂和性功能分别为 0.93 比 0.71、0.71 比 1.01、0.12 比 0.1 和 1.06 比 1.0。术前检查,两组问卷的四项(p=0.821、p=0.126、p=0.449、p=0.965)和总盆腔评分(p=0.756)中位数无差异。与基线相比,根治性子宫切除术组在术后 6 个月的总盆腔评分较差(p=0.03)。与基线相比,根治性子宫切除术组的膀胱(p=0.07)或肠道症状(p=0.07)无差异。与经阴道子宫颈切除术相比,行根治性子宫切除术的女性在术后 6 周时尿生殖发病率更高(p=0.025)。然而,在 6 个月的随访中,经历过尿生殖发病率和未经历过尿生殖发病率的患者的膀胱和盆腔评分的平均值相似(p=0.127、p=0.480)。
行腹腔镜辅助阴道根治性子宫颈切除术的患者在术前和术后的盆腔评分相似。然而,与基线评估相比,行根治性子宫切除术的患者在术后评估中总盆腔评分更差。根治性子宫切除术组在术后早期阶段的尿功能障碍比经阴道子宫颈切除术组更常见。